ClinicalTrials.govpublic full text
Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLC
carcinoma, non-small-cell lung, next-generation sequencing, chemotherapy, adjuvant, neoplasm, residual, circulating tumor dna, non-small cell lung cancer, adjuvant chemotherapy, minimal residual disease, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 806925
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.